Pharmabiz22h
US FDA grants orphan drug designation to Sanofi’s rilzabrutinib, an oral, reversible BTK inhibitor for two rare diseases
US FDA grants orphan drug designation to Sanofi’s rilzabrutinib, an oral, reversible BTK inhibitor for two rare diseases: Paris Friday, April 4, 2025, 14:00 Hrs [IST] The US Foo ...
Rolling Out12h
What happens when your body meets cold water
Discover the impact of cold water on your body from improved circulation to boosted energy and enhanced immune function.
UPSHER-SMITH TO SHOWCASE RARE DISEASE PORTFOLIO AT 2025 AAN ANNUAL MEETING
Company to Feature First and Only Ready-to-Use Liquid Vigabatrin at Booth #846 MAPLE GROVE, Minn., April 4, 2025 /PRNewswire/ -- Upsher-Smi ...
She Was Tired and Unsteady on Her Feet. Was It Just Age?
“Your blood count is dangerously low,” the doctor said over the phone. “I’m sending an ambulance to take you to the hospital ...